Changchun BCHT Biotechnology Co. (688276.SS)
- Previous Close
20.85 - Open
20.88 - Bid 20.89 x --
- Ask 20.88 x --
- Day's Range
20.79 - 20.97 - 52 Week Range
20.19 - 39.09 - Volume
933,636 - Avg. Volume
2,725,276 - Market Cap (intraday)
8.645B - Beta (5Y Monthly) --
- PE Ratio (TTM)
50.98 - EPS (TTM)
0.41 - Earnings Date --
- Forward Dividend & Yield 0.15 (0.72%)
- Ex-Dividend Date May 24, 2024
- 1y Target Est
--
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company's products include live herpes zoster vaccine; live varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and Rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China.
www.bchtpharm.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 688276.SS
View MorePerformance Overview: 688276.SS
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688276.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688276.SS
View MoreValuation Measures
Market Cap
8.62B
Enterprise Value
8.58B
Trailing P/E
50.85
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.69
Price/Book (mrq)
2.05
Enterprise Value/Revenue
7.65
Enterprise Value/EBITDA
45.20
Financial Highlights
Profitability and Income Statement
Profit Margin
15.40%
Return on Assets (ttm)
2.84%
Return on Equity (ttm)
4.16%
Revenue (ttm)
1.12B
Net Income Avi to Common (ttm)
172.59M
Diluted EPS (ttm)
0.41
Balance Sheet and Cash Flow
Total Cash (mrq)
224.1M
Total Debt/Equity (mrq)
4.16%
Levered Free Cash Flow (ttm)
-22.13M